CTI BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Aug '25 Aug 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.72	0.74	0.85
Debt / EBITDA Ratio	3.55	2.54	2.17
Debt / FCF Ratio	14.51	23.18	4.84
Asset Turnover	-	3.66	-
Inventory Turnover	-	106.66	-
Quick Ratio	1.43	1.41	1.15
Current Ratio	1.73	1.70	1.45
Return on Equity (ROE)	-	34.37%	-
Return on Assets (ROA)	-	7.20%	-
Return on Capital (ROIC)	-	11.49%	-
Return on Capital Employed (ROCE)	14.80%	22.00%	23.20%
Buyback Yield / Dilution	-	-20.41%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.